| Literature DB >> 28464830 |
Miguel A Cruz-Feliciano1, Christine Miranda-Díaz2, Diana M Fernández-Santos2, Darice Orobitg-Brenes3, Robert F Hunter-Mellado2, Ibis S Carrión-González3.
Abstract
BACKGROUND: This study evaluates the benefits of integrating behavioral health and trauma services for Latinas with a history drug use. Changes in quality of life (QOL) domains were documented after participation in a manualized intervention in a cohort of Latinas.Entities:
Keywords: Latinas; Quality of life; Substance use disorders; Women
Mesh:
Year: 2017 PMID: 28464830 PMCID: PMC5414180 DOI: 10.1186/s12955-017-0667-z
Source DB: PubMed Journal: Health Qual Life Outcomes ISSN: 1477-7525 Impact factor: 3.186
QOL mean scores at intake and follow-up for different populations
| QOL Domain | Intake | Six months |
| ES^ b | 1 - β c |
|---|---|---|---|---|---|
| Mean (SD) | Mean (SD) | ||||
| All women ( | |||||
| Physical | 57.3 (19.8) | 61.8 (20.7) | 0.015 | 0.239 | 0.69 |
| Psychological | 59.9 (20.8) | 66.2 (21.5) | 0.002 | 0.313 | 0.89 |
| Social | 58.9 (24.1) | 65.8 (26.4) | 0.008 | 0.262 | 0.77 |
| Environmental | 55.8 (18.9) | 60.6 (19.7) | 0.009 | 0.257 | 0.75 |
| Women without neurodevelopmental disorders and schizophrenia ( | |||||
| Physical | 58.8 (19.3) | 63.8 (19.0) | 0.012 | 0.280 | 0.72 |
| Psychological | 61.3 (20.1) | 67.5 (21.4) | 0.007 | 0.302 | 0.78 |
| Social | 59.4 (24.2) | 68.8 (24.3) | 0.001 | 0.379 | 0.93 |
| Environmental | 56.8 (18.5) | 62.9 (18.8) | 0.002 | 0.342 | 0.87 |
| Women with neurodevelopmental disorders and schizophrenia ( | |||||
| Physical | 52.1 (21.4) | 54.3 (25.2) | 0.620 | 0.105 | 0.08 |
| Psychological | 55.2 (23.2) | 61.2 (21.7) | 0.097 | 0.361 | 0.38 |
| Social | 57.1 (24.3) | 54.9 (31.4) | 0.734 | 0.072 | 0.06 |
| Environmental | 52.0 (20.1) | 52.1 (20.8) | 0.977 | 0.006 | 0.05 |
a p-value from paired t-test analysis
b ES = Effect size. ES^ the correlation between measures was considered in the calculation (Cohen’s method)
c Power obtained from the post-hoc analysis
Fig. 1Distribution of session completed by participants (n = 107). Note. Average number of sessions completed by each participant
Intake and follow-up substance use disorders, mental health disorders, and clinical variables (n = 107)
| Variable | Intake | Six months | ||
|---|---|---|---|---|
|
| % |
| % | |
| SUD a | ||||
| Alcohol | 47 | 43.9 | 31 | 29.0 |
| Cocaine | 34 | 31.8 | 17 | 15.9 |
| Heroin | 13 | 12.1 | 19 | 17.8 |
| Cannabis | 30 | 28.0 | 5 | 4.7 |
| Benzodiazepine | 19 | 17.8 | 12 | 11.2 |
| Tranquilizer | 7 | 6.5 | 2 | 1.9 |
| Mental Health Screening a | ||||
| Neurodevelopment | 18 | 16.8 | -- | -- |
| Schizophrenia | 6 | 5.6 | -- | -- |
| Bipolar | 21 | 19.6 | -- | -- |
| Depression | 41 | 38.3 | -- | -- |
| Anxiety | 13 | 12.1 | -- | -- |
| Trauma | 78 | 72.9 | -- | -- |
| Disruptive | 11 | 10.3 | -- | -- |
| Substance use | 99 | 92.5 | -- | -- |
| Personality | 20 | 18.7 | -- | -- |
| Suicidal Behavior | 8 | 7.5 | -- | -- |
| Clinical variables a | ||||
| HIV + | 16 | 15.0 | -- | -- |
| HBV + | 3 | 2.8 | -- | -- |
| HCV + | 11 | 10.3 | -- | -- |
SUD Substance use disorders
a Non-mutually exclusive
Substance-related DSM-5 diagnostic criteria at intake (n = 107)
| DSM-5 diagnostic criteria a | No diagnosis | Mild | Moderate | Severe | ||||
|---|---|---|---|---|---|---|---|---|
|
| % |
| % |
| % |
| % | |
| Alcohol | 42 | 39.3 | 12 | 11.2 | 22 | 20.6 | 31 | 29.0 |
| Cocaine | 35 | 32.7 | 7 | 6.5 | 10 | 9.3 | 55 | 51.4 |
| Cannabis | 38 | 35.5 | 17 | 15.9 | 26 | 24.3 | 26 | 24.3 |
| Opioid | 74 | 69.2 | 1 | 0.9 | 4 | 3.7 | 28 | 26.2 |
a Non-mutually exclusive
Change in QOL domains by sociodemographic characteristics (n = 86)
| Physical | Psychological | Social | Environmental | Physical | Psychological | Social | Environmental | |
|---|---|---|---|---|---|---|---|---|
| Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | |
| Age | ||||||||
| 18-34 | 57.8 (19.5) | 57.7 (21.0) | 57.9 (22.3) | 56.1 (20.3) | 65.1 (15.0) | 64.8 (19.1) |
| 61.0 (17.0) |
| 35–55 | 57.4 (19.9) | 63.5 (19.0) | 59.5 (25.3) | 56.2 (18.1) | 60.7 (21.7) | 67.0 (23.5) |
|
|
| 56–64 | 69.7 (13.5) | 66.0 (22.6) | 57.9 (21.8) | 67.1 (6.0) | 75.1 (8.7) | 80.4 (11.6) | 70.6 (23.8) | 74.3 (13.3) |
| Marital status | ||||||||
| Single | 51.4 (21.4) | 60.5 (20.3) | 65.5 (23.6) | 54.7 (13.6) |
| 69.5 (20.2) | 73.0 (24.1) | 59.3 (16.4) |
| Married | 59.7 (18.2) | 58.9 (20.6) | 69.6 (26.2) | 60.0 (21.6) |
| 67.9 (20.3) | 78.5 (20.4) | 67.7 (21.4) |
| Never married | 60.5 (18.8) | 62.1 (20.2) | 54.9 (23.0) | 56.5 (19.0) | 62.4 (19.5) | 66.9 (22.3) |
|
|
| Education | ||||||||
| Less than 12 grade | 56.4 (18.1) | 58.2 (19.6) | 63.7 (24.8) | 55.1 (17.4) | 65.4 (17.7) |
| 69.2 (25.2) |
|
| HS or higher | 59.3 (19.6) | 62.0 (20.2) | 58.4 (24.1) | 57.2 (18.9) |
| 66.5 (22.5) |
|
|
p-value obtained from paired t-test. *p < 0.05; **p < 0.01
Change in QOL domains by type of use, history of trauma, and mental health disorders as defined by DSM-5 (n = 86)
| Variable | Intake | Six-months | ||||||
|---|---|---|---|---|---|---|---|---|
| Physical | Psychological | Social | Environmental | Physical | Psychological | Social | Environmental | |
| Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | |
| Type of user | ||||||||
| 1 drug | 51.4 (19.5) | 56.1 (17.2) | 41.1 (21.5) | 51.3 (21.5) | 52.9 (21.6) | 63.8 (17.7) |
|
|
| Polydrug | 61.4 (19.4) | 63.7 (20.5) | 64.5 (22.3) | 59.7 (17.1) |
|
|
| 64.1 (17.4) |
| History of trauma | 59.9 (19.3) | 63.3 (20.4) | 59.9 (21.7) | 59.1 (18.2) |
|
|
|
|
| Bipolar disorder | 61.7 (20.4) | 61.7 (19.0) | 59.1 (22.0) | 63.9 (18.8) | 59.5 (22.6) | 65.7 (24.6) | 66.3 (28.3) | 65.2 (19.6) |
| Personality disorder | 54.7 (18.5) | 59.1 (20.6) | 55.0 (27.3) | 52.6 (17.3) | 59.4 (17.9) | 64.3 (21.3) | 63.5 (24.9) | 56.7 (17.7) |
| Depressive disorder | 58.5 (19.9) | 63.3 (19.7) | 61.6 (25.3) | 56.9 (17.8) |
|
|
|
|
| Anxiety disorder | 53.8 (19.7) | 55.8 (23.9) | 53.6 (20.1) | 55.7 (18.7) | 57.0 (19.2) | 66.8 (12.3) |
|
|
p-value obtained from paired t-test. *p < 0.05